BEN KOCHMAN: Open Payments
NPI 1730133109 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 29 payments from 12 companies in 2025. Trend: 2023 $312 · 2024 $625 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $134 |
| GENZYME CORPORATION | 4 | $114 |
| ABBVIE INC. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Journey Medical Corporation | 2 | $58 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| PFIZER INC. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Almirall LLC | 1 | $21 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, OTEZLA, RINVOQ, CIBINQO, COSENTYX.
Industry payments across CO — which companies pay providers there.
